Recent directives from the Trump administration have led to a pause in communications and purchasing at the National Institutes of Health (NIH), affecting ongoing research studies and clinical trials.
According to sources within the agency, the pause on purchasing, including supplies for studies, was implemented following a moratorium on public communication issued by the Department of Health and Human Services. This directive requires all communications to be reviewed by officials appointed by the Trump Administration.
